FORE School of Management hosted Oraculum 2025, bringing together industry leaders, policymakers and aspiring professionals ...

FORE School of Management successfully hosted Oraculum 2025, bringing together industry leaders, policymakers, and aspiring professionals for two days of thought-provoking discussions. Centered around ...

For comprehensive analysis and additional insights, including 8 more ProTips and detailed financial metrics, explore GSK's Pro Research Report, available exclusively on InvestingPro. This report ...

According to InvestingPro analysis, GSK maintains strong financial health with consistent profitability and dividend payments spanning 25 years. This submission is based on the Phase III MATINEE ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

According to InvestingPro analysis, GSK maintains strong financial health with consistent profitability and dividend payments spanning 25 years. This submission is based on the Phase III MATINEE trial ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its ...

DelveInsight's HPV16-Positive Head and Neck Squamous Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment practices, HPV16+ HNSCC emerging drugs, market ...

Ben Hargreaves examines the reasons supplied by the survey and why GSK is invested in the answers. The emergence of COVID-19 meant that public awareness around vaccination and its importance in ...

The global penicillin drug market size was valued at US$ 8.71 billion in 2023 and is projected to reach US$ 12.08 billion by 2032, registering a CAGR of 3.7% during the forecast period from 2024 to ...